Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Fact Sheets Blood safety in Canada: Restriction lifted for men who have sex with men [2022-04-28] Biosimilar biologic drugs in Canada: Fact Sheet [2019-08-27] Plasma donation in Canada [2013-04-11] Questions and Answers: Regulation of Medicinal Maggots / Medicinal Leeches…
Association Bilateral Meeting - BIOTECanada - Meeting Minutes - 2011-11-16 Bilateral meeting between BIOTECanada and Health Canada Wednesday, November 16, 2011 1:30 - 3:30pm 200 Tunney's Pasture Driveway, Ottawa, Ontario Table of Contents Attendees Welcome and introductions…
Activities - Canada.ca
Handbook for health care professionals on biosimilar biologic drugs: Case studies Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Kanjinti, a biosimilar to Herceptin Inflectra…
Handbook for health care professionals on biosimilar biologic drugs: Appendices Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Glossary Definitions Glossary ADA anti-drug…
Handbook for health care professionals on biosimilar biologic drugs: Access to biosimilars and communicating with patients Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Health…
Handbook for health care professionals on biosimilar biologic drugs: Monitoring safety and effectiveness Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page The risk management plan…
Handbook for health care professionals on biosimilar biologic drugs: Authorization of biosimilars Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Regulatory authorization How Canada…
Handbook for health care professionals on biosimilar biologic drugs: Immunogenicity Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies Addressing a key safety issue: immunogenicity Biologic drugs…
Handbook for health care professionals on biosimilar biologic drugs: Data requirements, labelling and indications Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Data requirements…
Early release: coverage is bounded to the current corpus, and features may change.
